Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYPH - Cytoclonal Pharmaceutics -- Ignore unavailable to you. Want to Upgrade?

To: Candle stick who wrote (115)	3/30/1998 2:50:00 PM
From: Doug Coughlan	Respond to of 428

I don't know why the current 13D's were filed but it is interesting that the number of shares indicated in the 13D's match up with the number of shares indicated as being owned in a SB-2A that was filed on 7/25/96. This filing can be accessed at the Free Edgar site. Janseen & Meyers Associates were shown as owning 1,689,500 shares in the SB-2A and the 13D filed on 3/27/98 . Meyers was indicated as owning 849,500 shares in the SB-2A and in the 13D filed on 3/26/98. Jenseen was shown as owning 840,000 shares in the SB-2A and in the 13D filed on 3/27/98. Again I don't know if there is a requirement to report something that had been previously reported, but I question whether these are new buys.